Table 7 Contrast tests of mean score differences on symptom severity, quality of life, and four patterns of body constitution at three post-tests (n = 240)

T2

CS vs. placebo

23.12 (7.59)

-26.13 (0.001)

11.67 (3.96)

-12.81 (0.001)

-3.29 (1.99)

6.18 (0.002)

5.88 (2.56)

-7.87 (0.002)

4.45 (3.08)

-8.53 (0.006)

6.43 (2.45)

-5.22 (0.03)

CS vs. YS

6.61 (7.57)

-5.28 (0.49)

5.05 (3.95)

-4.23 (0.28)

-1.32 (1.99)

3.16 (0.11)

5.74 (2.56)

-2.46 (0.34)

3.97 (3.08)

-5.08 (0.10)

3.24 (2.44)

-1.94 (0.43)

YS vs. placebo

2.33 (7.61)

-20.85 (0.006)

2.05 (3.97)

-8.58 (0.03)

-1.97 (2.01)

3.01 (0.13)

0.14(2.58)

-5.41 (0.04)

0.48 (3.09)

-3.45 (0.27)

3.19 (2.46)

-3.27 (0.18)

T3

CS vs. placebo

29.64 (7.59)

-32.64 (<0.0005)

15.61 (3.96)

-16.76 (<0.0005)

-3.03 (1.99)

5.93 (0.003)

4.49 (2.57)

-6.47 (0.01)

2.35 (3.09)

-6.42 (0.04)

3.79 (2.45)

-2.58 (0.29)

CS vs. YS

12.12 (7.57)

-10.79 (0.15)

6.12 (3.95)

-5.31 (0.18)

-1.00 (1.99)

2.84 (0.15)

6.14 (2.56)

-2.85 (0.26)

4.29 (3.09)

-5.40 (0.08)

2.09 (2.44)

-0.80 (0.74)

YS vs. placebo

2.12 (7.61)

-21.85 (0.004)

2.75 (3.98)

-11.46 (0.004)

-2.03 (2.00)

3.09 (0.12)

-1.65 (2.58)

-3.62 (0.16)

-1.94 (3.10)

-1.03 (0.74)

1.70 (2.46)

-1.78 (0.47)

T4

CS vs. placebo

31.54 (7.59)

-34.54 (<0.0005)

14.71 (3.96)

-15.86 (<0.0005)

0.95 (1.99)

1.95 (0.33)

3.71 (2.56)

-5.70 (0.03)

2.83 (3.05)

-6.90 (0.02)

8.35 (2.44)

-7.14 (0.003)

CS vs. YS

8.80 (7.57)

-7.47 (0.32)

4.93 (3.94)

-4.11 (0.30)

0.57 (1.99)

1.27 (0.52)

4.54 (2.56)

-1.27 (0.62)

3.92 (3.04)

-5.03 (0.10)

4.03 (2.44)

-2.73 (0.26)

YS vs. placebo

2.93 (7.61)

-27.07 (<0.0005)

2.97 (3.97)

-11.74 (0.003)

0.38 (2.00)

0.67 (0.74)

-0.83 (2.57)

-4.44 (0.08)

-1.09 (3.06)

-1.87 (0.54)

4.32 (2.45)

-4.40 (0.07)